Q1 FY27 results: profit down 42%, revenue dips 8%; new MD appointed
DSFCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
DCM Shriram Fine Chemicals posted Q1 FY27 (Jun 2026) results: standalone revenue from operations fell about 8 percent YoY to Rs 90.18 crore (vs Rs 97.92 crore), while net profit dropped 42 percent to Rs 2.42 crore (vs Rs 4.13 crore). MD and CEO Akshay Dhar resigned; Rudra Shriram, son of Chairman Alok B Shriram, named new MD for 5 years. Rakesh Malhotra joins as Independent Director. Prior period figures restated due to composite scheme effective December 2025.
Weak quarter with profit down 42% YoY. Promoter-family MD transition adds near-term focus question, though continuity of group leadership is maintained.